.parent-daily-progress{margin:18px 0;background:linear-gradient(125deg,#6756df,#8073e9);color:#fff;border-radius:22px;padding:20px 23px;display:flex;align-items:center;justify-content:space-between;gap:18px}.parent-daily-progress-label{display:block;opacity:.78;font-size:.8rem;margin-bottom:5px}.parent-daily-progress-amount{display:block;font-size:1.2rem}.parent-daily-progress-message{margin:6px 0 0;color:#ebe8ff;font-size:.78rem;line-height:1.35}.parent-daily-progress-ring{--parent-progress:0deg;position:relative;flex:0 0 62px;width:62px;height:62px;border-radius:50%;display:grid;place-items:center;background:conic-gradient(#fff var(--parent-progress),#bdb5ff 0)}.parent-daily-progress-ring:before{content:"";position:absolute;inset:4px;border-radius:50%;background:#7566e4}.parent-daily-progress-ring span{position:relative;z-index:1;font-size:.76rem;font-weight:700}@media(max-width:600px){.parent-daily-progress{padding:18px}.parent-daily-progress-ring{flex-basis:56px;width:56px;height:56px}}